Subscribe
shutterstock_1125283274_panuwach
panuwach / Shutterstock.com
23 July 2019AmericasSarah Morgan

Sigma-Aldrich submits CRISPR petition at USPTO

Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office (USPTO) to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley (UC Berkeley).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Merck and Evotec strike CRISPR licensing deal
14 November 2019   Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.
Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.
Americas
Merck KGaA secures second US CRISPR patent
9 April 2020   Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Europe
Merck and Evotec strike CRISPR licensing deal
14 November 2019   Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.
Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.
Americas
Merck KGaA secures second US CRISPR patent
9 April 2020   Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.

More on this story

Europe
Merck and Evotec strike CRISPR licensing deal
14 November 2019   Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.
Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.
Americas
Merck KGaA secures second US CRISPR patent
9 April 2020   Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York